4-((3-fluorophenyl)ethynyl)benzoic acid | 387398-44-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-((3-fluorophenyl)ethynyl)benzoic acid
• 英文别名: 4-[2-(3-fluorophenyl)ethynyl]benzoic acid
• CAS: 387398-44-9
• 化学式: C₁₅H₉FO₂
• 分子量: 240.234
• InChiKey: AQZZCFKUVBQDBB-UHFFFAOYSA-N

物化性质

• 沸点：
  410.8±30.0 °C(Predicted)
• 密度：
  1.32±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  18
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  4-((3-fluorophenyl)ethynyl)benzoic acid 在 氯化亚砜 作用下， 反应 0.5h， 生成 4-((3-fluorophenyl)ethynyl)benzoyl chloride
  参考文献：
  名称：

  [EN] METABOTROPIC GLUTAMATE RECEPTORS 5 MODULATORS AND METHODS OF USE THEREOF
  [FR] MODULATEURS DES RÉCEPTEURS 5 MÉTABOTROPIQUES DU GLUTAMATE ET LEURS PROCÉDÉS D'UTILISATION

  摘要：

  公开号：

  WO2012162635A8
• 作为产物：
  描述：

  1-乙炔基-3-氟苯 在 palladium diacetate copper(l) iodide 、 水 、 三乙胺 、 三苯基膦 、 sodium hydroxide 作用下， 以 N,N-二甲基甲酰胺 、 乙腈 为溶剂， 反应 8.5h， 生成 4-((3-fluorophenyl)ethynyl)benzoic acid
  参考文献：
  名称：

  [EN] METABOTROPIC GLUTAMATE RECEPTORS 5 MODULATORS AND METHODS OF USE THEREOF
  [FR] MODULATEURS DES RÉCEPTEURS 5 MÉTABOTROPIQUES DU GLUTAMATE ET LEURS PROCÉDÉS D'UTILISATION

  摘要：

  公开号：

  WO2012162635A8

文献信息

• BENZAMIDE mGluR5 POSITIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING SAME
  申请人：Conn P. Jeffrey

  公开号：US20090042855A1

  公开（公告）日：2009-02-12

  In one aspect, the invention relates to compounds, including phenylethynylbenzamide derivatives, cycloalkylethynylbenzamide derivatives, styrylbenzamide derivatives, 4-(3-phenyl-1,2,4-oxadiazol-5-yl)benzamide derivatives, 4-(pyridinylethynyl)benzamide derivatives, and N 1 -phenylterephthalamide derivatives, which are useful as positive allosteric modulators of the metabotropic glutamate receptor subtype 5 (mGluR5); synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with glutamate dysfunction using the compounds and compositions. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

  本发明涉及化合物，包括苯乙炔基苯甲酰胺衍生物、环烷基乙炔基苯甲酰胺衍生物、苯乙烯基苯甲酰胺衍生物、4-(3-苯基-1,2,4-噁唑-5-基)苯甲酰胺衍生物、4-(吡啶乙炔基)苯甲酰胺衍生物和N1-苯基对苯二甲酰胺衍生物，它们是代谢型谷氨酸受体亚型5 (mGluR5) 的正向变构调节剂；制备这些化合物的合成方法；含有这些化合物的药物组合物；以及使用这些化合物和组合物治疗与谷氨酸功能失调相关的神经和精神障碍的方法。本摘要旨在作为搜索特定领域的扫描工具，不限制本发明。
• Benzamide mGluR5 positive allosteric modulators and methods of making and using same
  申请人：Conn P. Jeffrey

  公开号：US08853392B2

  公开（公告）日：2014-10-07

  In one aspect, the invention relates to compounds, including phenylethynylbenzamide derivatives, cycloalkylethynylbenzamide derivatives, styrylbenzamide derivatives, 4-(3-phenyl-1,2,4-oxadiazol-5-yl)benzamide derivatives, 4-(pyridinylethynyl)benzamide derivatives, and N1-phenylterephthalamide derivatives, which are useful as positive allosteric modulators of the metabotropic glutamate receptor subtype 5 (mGluR5); synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with glutamate dysfunction using the compounds and compositions. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

  该发明涉及化合物，包括苯乙炔基苯甲酰胺衍生物、环烷基乙炔基苯甲酰胺衍生物、苯乙烯基苯甲酰胺衍生物、4-(3-苯基-1,2,4-噁唑-5-基)苯甲酰胺衍生物、4-(吡啶基乙炔基)苯甲酰胺衍生物和N1-苯基对苯二甲酰胺衍生物，它们可用作代谢型谷氨酸受体亚型5(mGluR5)的正向变构调节剂；制备该化合物的合成方法；包括该化合物的药物组成物；以及使用该化合物和组成物治疗与谷氨酸功能障碍相关的神经和精神障碍的方法。本摘要旨在作为搜索特定领域的扫描工具，不限制本发明。
• METABOTROPHIC GLUTAMATE RECEPTOR 5 MODULATORS AND METHODS OF USE THEREOF
  申请人：Heffernan Michele L. R.

  公开号：US20140221332A1

  公开（公告）日：2014-08-07

  Compounds that modulate GluR5 activity and methods of using the same are disclosed.

  本发明揭示了调节GluR5活性的化合物及其使用方法。
• Exploration of Allosteric Agonism Structure–Activity Relationships within an Acetylene Series of Metabotropic Glutamate Receptor 5 (mGlu₅) Positive Allosteric Modulators (PAMs): Discovery of 5-((3-Fluorophenyl)ethynyl)-<i>N</i>-(3-methyloxetan-3-yl)picolinamide (ML254)
  作者：Mark Turlington、Meredith J. Noetzel、Aspen Chun、Ya Zhou、Rocco D. Gogliotti、Elizabeth D. Nguyen、Karen J. Gregory、Paige N. Vinson、Jerri M. Rook、Kiran K. Gogi、Zixiu Xiang、Thomas M. Bridges、J. Scott Daniels、Carrie Jones、Colleen M. Niswender、Jens Meiler、P. Jeffrey Conn、Craig W. Lindsley、Shaun R. Stauffer

  DOI：10.1021/jm401028t

  日期：2013.10.24

  Positive allosteric modulators (PAMs) of metabotropic glutamate receptor 5 (mGlu(5)) represent a promising therapeutic strategy for the treatment of schizophrenia. Both allosteric agonism and high glutamate fold-shift have been implicated in the neurotoxic profile of some mGlu(5) PAMs; however, these hypotheses remain to be adequately addressed. To develop tool compounds to probe these hypotheses, the structure-activity relationship of allosteric agonism was examined within an acetylenic series of mGlu(5) PAMs exhibiting allosteric agonism in addition to positive allosteric modulation (ago-PAMs). PAM 38t, a low glutamate fold-shift allosteric ligand (maximum fold-shift similar to 3.0), was selected as a potent PAM with no agonism in the in vitro system used for compound characterization and in two native electrophysiological systems using rat hippocampal slices. PAM 38t (ML254) will be useful to probe the relative contribution of cooperativity and allosteric agonism to the adverse effect liability and neurotoxicity associated with this class of mGlu(5) PAMs.
• BENZAMIDE MGLUR5 POSITIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING SAME
  申请人：VANDERBILT UNIVERSITY

  公开号：EP2162136A1

  公开（公告）日：2010-03-17